SEB Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.79M Sell
8,837
-3,686
-29% -$1.91M 0.02% 461
2026
Q2
$6.79M Sell
12,523
-5,208
-29% -$2.93M 0.03% 408
2026
Q1
$10.5M Buy
+17,731
New +$8.83M 0.04% 307

Other funds holding UTHR

SEB Asset Management's UTHR Position: Q3 2026 in Review

SEB Asset Management reduced its United Therapeutics (UTHR) stake by 29% in Q3 2026, selling an estimated $1.91M and leaving 8,837 shares worth $4.79M. The position accounts for 0.02% of the portfolio, ranked #461.

SEB Asset Management first reported a position in UTHR in Q1 2026 and has held it in 3 quarters since. The position peaked at $10.5M in Q1 2026. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • SEB Asset Management held 8,837 shares of United Therapeutics worth $4.79M as of Q3 2026.
  • SEB Asset Management sold 3,686 United Therapeutics shares in Q3 2026, an estimated $1.91M.
  • United Therapeutics made up 0.02% of SEB Asset Management's portfolio in Q3 2026, its #461 holding.
  • SEB Asset Management first reported a position in United Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's United Therapeutics position peaked at $10.5M in Q1 2026.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.